期刊文献+

右美托咪定和异丙酚用于冠心病患者非心脏手术的镇痛效果比较 被引量:15

Analgesic effect of dexmedetomidine versus propofol on patients with coronary heart disease undergoing noncardiac surgery
原文传递
导出
摘要 目的比较右美托咪定与异丙酚在冠心病患者非心脏手术中的镇痛效果。方法选择2009年9月至2011年9月于我院收治的硬膜外麻醉下择期行上腹部手术的冠心病患者86例,年龄55~76岁,体质量42~60kg,随机分为右美托咪定组和异丙酚组,每组43例,采用视觉模拟评分法(VAs)检测患者术前、术后4、24、48h末血清皮质醇、胰岛素和血糖的含量变化来评价两组患者的镇痛效果,并术后进行满意度调查。结果术后不同时点VAS镇痛评分和Ramsay镇静评分结果显示,右美托咪定组患者的镇痛镇静效果优于异丙酚组,差异有统计学意义(t=5.368、2.262、7.147、5.881、7.861、4.810,P〈0.05)。右美托咪定组患者清皮质醇、胰岛素和血糖浓度在术前及术后各个时间点均低于异丙酚组患者,差异有统计学意义(t=3.076、2.042、4.090,P〈O.05),且93.0%(40/43)的患者对Dex组满意。结论右美托咪定用于冠心病患者非心脏手术的镇痛效果优于异丙酚,且安全可行。 Objective To compare the analgesic effect of dexmedetomidine and propofol on patients with coronary heart disease undergoing noncardiac surgery. Methods 86 patients in our hospital from Sep 2009 to Sep 2011 aged 55-76 years weighing 42-60 kg, who were scheduled for epidural anesthesia in routine,were randomly assigned to 2 groups: dexmedtomidine (Dex) group and propofol group (n = 43, each). Visual analogue scale/score (VAS) analgesia score and ramsay sedation score were used to observe the analgesic effect after surgery. Serum concentration of cortisol, insulin and glucose were observed and compared between Dex and propofol group before and 4, 24, 48 h after surgery. Patient satisfaction was surveyed. Results The analgesic effect evaluated by VAS and Ramsay scores was better in Dex group than in propofol group at different time after surgery (t= 5. 368, 2. 262, 7. 147, 5. 881, 7. 861, 4. 810,all P〈0.05). Serum concentrations of cortisol, insulin and glucose were lower in Dex group than in propofol group before and 4, 24, 48 h after surgery (t= 3.076, 2.042, 4.090,all P%0.05). The satisfaction rate was 93. 0% (40/43) in Dex group. Conclusions Dexmedetomidine has a better analgesic effect than propofol, and it is safe and feasible for patients with coronary heart disease undergoing noncardiac surgery.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2013年第11期1161-1163,共3页 Chinese Journal of Geriatrics
关键词 右美托咪定 二异丙酚 冠心病 Dexmedtomidine Propofoll Coronary
  • 相关文献

参考文献10

  • 1Cannon CP, Shah S, Dansky HM, et al. Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med, 2010, 363: 2406-2415.
  • 2Kaptoge S, Di Angelantonio E, Lowe G, et al. C- reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant recta-analysis. Lancet, 2010, 375.. 132- 140.
  • 3Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA, 2010, 303: 1610-1616.
  • 4Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically Ⅲ patients. JAMA, 2009, 301: 489-499.
  • 5Pandharipande PP, Sanders RD, Girard TD, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care, 2010, 14: 1-12.
  • 6郭立新,马靖,程洋,张丽娜,潘琦,王晓霞.老年2型糖尿病患者并发冠心病的危险因素分析[J].中华老年医学杂志,2012,31(4):286-289. 被引量:23
  • 7梁伟,杨晖,吴春芳,余强,张大东,陆国平.不同调脂方案对冠心病患者C反应蛋白和CD40配体的影响[J].中华老年医学杂志,2010,29(4):285-288. 被引量:6
  • 8Tsui BCH, Rashiq S, Schopflocher D, et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anesth, 2010, 57 : 107- 112.
  • 9Tiwari AK, Agrawai J, Tayal S, et al. Anesthetic management of peripartum cardiomyopathy using " epidural volume extension" technique: A case series. Ann Cardiac Anesth, 2012, 15: 44-46.
  • 10Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intens Care Med, 2010, 36: 926-939.

二级参考文献30

  • 1Brown BG,Zhao XQ.Importace of endothelial function in mediating the benefits of lipid2 lowering therapy.Am J Cardiol,1998,82:49-52.
  • 2Williams JK,Sukhova GK,Herrington DM,et al.Pravastatin has cholesterol lowering independent effects on the artery wall of atherosclerotic monkeys.J Am Coll Cardiol,1998,31:684-691.
  • 3Cannon CP,Braunwald E,Mc Cabe CH,et al.Comparison of intensive and moderate lipid-lowering with statins after acute coronary syndromes.N Engl J Med,2004,350:1-10.
  • 4Waters DD,LaRosa JC,Barter P,et al.Effects of high-dose atorvastatin on cerebrovaseular events in patients with stable coronary disease in the TNT (treating to new targets) study.J Am Coil Cardiol,2006,48:1793-1799.
  • 5Piorkowski M,Fischer S,Stellbaum C,et al.Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone:is sufficient cholesterol-lowering enough to inhibit platelets? J Am Coll Cardiol,2007,49:1035-1042.
  • 6Shari SB,Nade R,Paul MR,et al.High sensitivity reactive protein:clinical importance.Curt Probl Cardiol,2004,29:439-493.
  • 7Paul MR,Christopher PC,David M,et al.C-reactive protein levels and outcomes after statin therapy.N Engl J Med,2005,352:20-28.
  • 8Pearson T,Ballantyne C,Sisk C,et al.Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.Am J Cardiol,2007,99:1706-1713.
  • 9Sager PT,Melani L,Lipka L,et al.Effect of coadministration of ezetimibe and simvastatin on highsensitivity C-reactive protein.Am J Cardiol,2003,92 1414-1423.
  • 10Thomas AP,Margo A,Patrick DE,et al.Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-denstiy lipoprotein cholesterol goal attainment in patients of different races and ethnicities:a substudy of the ezetimihe add-on to statin for effectiveness trial.Mayo Clin Proc,2006,81:1177-1185.

共引文献27

同被引文献105

引证文献15

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部